A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
Public ClinicalTrials.gov record NCT03184870. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2 Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Study identification
- NCT ID
- NCT03184870
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 332 participants
Conditions and interventions
Conditions
Interventions
- 5-fluorouracil (5-FU) Drug
- BMS-813160 Drug
- Gemcitabine Drug
- Irinotecan Drug
- Leucovorin Drug
- Nab-paclitaxel Drug
- Nivolumab Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 7, 2017
- Primary completion
- Apr 5, 2023
- Completion
- Jun 13, 2023
- Last update posted
- Oct 8, 2025
2017 – 2023
United States locations
- U.S. sites
- 28
- U.S. states
- 20
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0003 | Birmingham | Alabama | 35249 | — |
| Local Institution - 0026 | Phoenix | Arizona | 85054 | — |
| Local Institution - 0002 | Los Angeles | California | 90033 | — |
| Local Institution - 0025 | Los Angeles | California | 90033 | — |
| Local Institution - 0041 | Orange | California | 92868-3201 | — |
| Local Institution - 0015 | Aurora | Colorado | 80045 | — |
| Local Institution - 0018 | Washington D.C. | District of Columbia | 20007 | — |
| Local Institution - 0048 | Brooksville | Florida | 34613 | — |
| Local Institution - 0047 | St. Petersburg | Florida | 33705 | — |
| Local Institution - 0005 | Baltimore | Maryland | 21287 | — |
| Local Institution - 0033 | Boston | Massachusetts | 02114 | — |
| Local Institution - 0027 | Rochester | Minnesota | 55905-0001 | — |
| Local Institution - 0039 | Hattiesburg | Mississippi | 39401 | — |
| Local Institution - 0023 | St Louis | Missouri | 63110 | — |
| Local Institution - 0004 | Hackensack | New Jersey | 07601 | — |
| Local Institution - 0017 | New York | New York | 10065 | — |
| Local Institution - 0024 | Rochester | New York | 14642 | — |
| Local Institution - 0046 | Charlotte | North Carolina | 28204 | — |
| Local Institution - 0044 | Cleveland | Ohio | 44106-5055 | — |
| Local Institution - 0021 | Cleveland | Ohio | 44195 | — |
| Local Institution - 0037 | Allentown | Pennsylvania | 18103 | — |
| Local Institution - 0014 | Philadelphia | Pennsylvania | 19104 | — |
| Local Institution - 0020 | Philadelphia | Pennsylvania | 19107 | — |
| Local Institution - 0045 | Charleston | South Carolina | 29425 | — |
| Local Institution - 0034 | Nashville | Tennessee | 37203 | — |
| Local Institution - 0038 | Nashville | Tennessee | 37232 | — |
| Local Institution - 0016 | Salt Lake City | Utah | 84112 | — |
| Local Institution - 0042 | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03184870, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2025 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03184870 live on ClinicalTrials.gov.